2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Renal Cell
65
Sarcoma
40
Neoplasm Metastasis
22
Neoplasms
20
Ovarian Neoplasms
17
Breast Neoplasms
17
Carcinoma, Non-Small-Cell Lung
15
Recurrence
7
Leiomyosarcoma
7
Kidney Neoplasms
7
Melanoma
6
Liposarcoma
6
Hemangiosarcoma
6
Glioblastoma
6
Fallopian Tube Neoplasms
6
Thyroid Neoplasms
5
Prostatic Neoplasms
5
Neurofibrosarcoma
5
Lung Neoplasms
5
Urinary Bladder Neoplasms
4
Solid Tumors
4
Sarcoma, Synovial
4
Pancreatic Neoplasms
4
Osteosarcoma
4
Histiocytoma, Malignant Fibrous
4
Dermatofibrosarcoma
4
Clear-cell metastatic renal cell carcinoma
4
Chondrosarcoma, Extraskeletal Myxoid
4
Uterine Cervical Neoplasms
3
Small Cell Lung Carcinoma
3
Interventions
apatinib
9
Paclitaxel
9
Capecitabine
7
Oxaliplatin
6
camrelizumab
5
Cisplatin
5
S 1 (combination)
4
Fluorouracil
3
Docetaxel
3
130-nm albumin-bound paclitaxel
3
titanium silicide
2
Leucovorin
2
Drug Therapy
2
vorolanib
1
trifluridine tipiracil drug combination
1
tipiracil
1
spartalizumab
1
rucaparib
1
relatlimab
1
raltitrexed
1
pazopanib
1
olaparib
1
lobaplatin
1
linrodostat
1
ezogabine
1
endostar protein
1
durvalumab
1
dacomitinib
1
capivasertib
1
Trifluridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Advanced Gastric Cancer
×
pazopanib
×
Clear all
NCT01503372
2019-02-12
PaFLO
Charite University, Berlin, Germany
Phase 2
Completed
75 enrolled